-
Je něco špatně v tomto záznamu ?
Characterization of AMBN I and II Isoforms and Study of Their Ca2+-Binding Properties
V. Vetyskova, M. Zouharova, L. Bednarova, O. Vaněk, P. Sázelová, V. Kašička, J. Vymetal, J. Srp, M. Rumlová, T. Charnavets, K. Postulkova, JE. Reseland, K. Bousova, J. Vondrasek
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
RVO: 61388963
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
No. CZ.02.1.01/0.0/0.0/16_019/0000729
European Regional Development Fund; OP RDE; Project: "ChemBioDrug"
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
33291486
DOI
10.3390/ijms21239293
Knihovny.cz E-zdroje
- MeSH
- biologické modely MeSH
- hydrodynamika MeSH
- lidé MeSH
- multimerizace proteinu MeSH
- protein - isoformy MeSH
- proteiny vázající vápník chemie metabolismus MeSH
- proteiny zubní skloviny chemie metabolismus MeSH
- spektrální analýza MeSH
- teplota MeSH
- vápník metabolismus MeSH
- vazba proteinů MeSH
- vnitřně neuspořádané proteiny metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Ameloblastin (Ambn) as an intrinsically disordered protein (IDP) stands for an important role in the formation of enamel-the hardest biomineralized tissue commonly formed in vertebrates. The human ameloblastin (AMBN) is expressed in two isoforms: full-length isoform I (AMBN ISO I) and isoform II (AMBN ISO II), which is about 15 amino acid residues shorter than AMBN ISO I. The significant feature of AMBN-its oligomerization ability-is enabled due to a specific sequence encoded by exon 5 present at the N-terminal part in both known isoforms. In this study, we characterized AMBN ISO I and AMBN ISO II by biochemical and biophysical methods to determine their common features and differences. We confirmed that both AMBN ISO I and AMBN ISO II form oligomers in in vitro conditions. Due to an important role of AMBN in biomineralization, we further addressed the calcium (Ca2+)-binding properties of AMBN ISO I and ISO II. The binding properties of AMBN to Ca2+ may explain the role of AMBN in biomineralization and more generally in Ca2+ homeostasis processes.
2nd Faculty of Medicine Charles University 5 Uvalu 84 150 06 Prague 5 Czech Republic
Department of Biomaterials Institute of Clinical Dentistry University of Oslo 0317 Oslo Norway
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21011757
- 003
- CZ-PrNML
- 005
- 20210713154929.0
- 007
- ta
- 008
- 210420s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms21239293 $2 doi
- 035 __
- $a (PubMed)33291486
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Vetyskova, Veronika $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic ; Department of Biochemistry and Microbiology, University of Chemistry and Technology Prague, Technicka 5, 166 28 Prague, Czech Republic
- 245 10
- $a Characterization of AMBN I and II Isoforms and Study of Their Ca2+-Binding Properties / $c V. Vetyskova, M. Zouharova, L. Bednarova, O. Vaněk, P. Sázelová, V. Kašička, J. Vymetal, J. Srp, M. Rumlová, T. Charnavets, K. Postulkova, JE. Reseland, K. Bousova, J. Vondrasek
- 520 9_
- $a Ameloblastin (Ambn) as an intrinsically disordered protein (IDP) stands for an important role in the formation of enamel-the hardest biomineralized tissue commonly formed in vertebrates. The human ameloblastin (AMBN) is expressed in two isoforms: full-length isoform I (AMBN ISO I) and isoform II (AMBN ISO II), which is about 15 amino acid residues shorter than AMBN ISO I. The significant feature of AMBN-its oligomerization ability-is enabled due to a specific sequence encoded by exon 5 present at the N-terminal part in both known isoforms. In this study, we characterized AMBN ISO I and AMBN ISO II by biochemical and biophysical methods to determine their common features and differences. We confirmed that both AMBN ISO I and AMBN ISO II form oligomers in in vitro conditions. Due to an important role of AMBN in biomineralization, we further addressed the calcium (Ca2+)-binding properties of AMBN ISO I and ISO II. The binding properties of AMBN to Ca2+ may explain the role of AMBN in biomineralization and more generally in Ca2+ homeostasis processes.
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a proteiny vázající vápník $x chemie $x metabolismus $7 D002135
- 650 _2
- $a proteiny zubní skloviny $x chemie $x metabolismus $7 D003746
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrodynamika $7 D057446
- 650 _2
- $a vnitřně neuspořádané proteiny $x metabolismus $7 D064267
- 650 _2
- $a biologické modely $7 D008954
- 650 _2
- $a vazba proteinů $7 D011485
- 650 _2
- $a protein - isoformy $7 D020033
- 650 _2
- $a multimerizace proteinu $7 D055503
- 650 _2
- $a spektrální analýza $7 D013057
- 650 _2
- $a teplota $7 D013696
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Zouharova, Monika $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic ; Second Faculty of Medicine, Charles University, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 700 1_
- $a Bednarova, Lucie $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Vaněk, Ondřej $u Department of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 128 40 Prague, Czech Republic
- 700 1_
- $a Sázelová, Petra $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Kašička, Václav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Vymetal, Jiri $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Srp, Jaroslav $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Rumlová, Michaela $u Department of Biotechnology, University of Chemistry and Technology Prague, Technicka 5, 166 28 Prague, Czech Republic
- 700 1_
- $a Charnavets, Tatsiana $u Institute of Biotechnology of the Czech Academy of Sciences, Prumyslova 595, 252 50 Vestec, Czech Republic
- 700 1_
- $a Postulkova, Klara $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Reseland, Janne E $u Department of Biomaterials, Institute of Clinical Dentistry, University of Oslo, 0317 Oslo, Norway
- 700 1_
- $a Bousova, Kristyna $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 700 1_
- $a Vondrasek, Jiri $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo nam. 2, 160 00 Prague, Czech Republic
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 21, č. 23 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33291486 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210420 $b ABA008
- 991 __
- $a 20210713154926 $b ABA008
- 999 __
- $a ok $b bmc $g 1650203 $s 1132136
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 21 $c 23 $e 20201205 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- GRA __
- $a RVO: 61388963 $p Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences
- GRA __
- $a No. CZ.02.1.01/0.0/0.0/16_019/0000729 $p European Regional Development Fund; OP RDE; Project: "ChemBioDrug"
- LZP __
- $a Pubmed-20210420